Login
$LRMR
$2.39 +$0.15 (6.7%) Close

Company Executives

$LRMR Management Team

Dr. Russell Clayton

Chief Medical Officer

Age 64
Compensation -
Sex Male

Dr. Gopi Shankar

Chief Development Officer

Age 54
Compensation $1.165M USD
Sex Male

Mr. Joseph Truitt

Independent Chairman of the Board

Age 60
Compensation $185.5K USD
Sex Male

Dr. Carole Ben-Maimon

President

Chief Executive Officer

Director

Age 66
Compensation $2.512M USD
Sex Female

Mr. Michael Celano

Chief Financial Officer

Secretary

Age 66
Compensation $1.385M USD
Sex Male
Directors
6
serving now
Independent
5 of 6
stated in the proxy
Average tenure
6.5 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Frank Thomas
56 2014
12 years
Independent
Audit · Chair Compensation
Spero Therapeutics, Inc. $82,400
Carole S. Ben-Maimon
67 2020
6 years
Not independent None stated None stated Paid as CEO
Joseph Truitt
61 2020
6 years
Independent
Audit Compensation · Chair
None stated $109,900
Jonathan Leff
57 2020
6 years
Independent
Compensation Nominating and Corporate Governance · Chair
None stated $74,900
Jeffrey W. Sherman
71 2023
3 years
Independent
Nominating and Corporate Governance
Xeris Biopharma Holdings, Inc. Not stated
Thomas E. Hamilton
58 2020
6 years
Independent
Audit Nominating and Corporate Governance
Annaly Capital Management Inc. $73,650

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Apr 20, 2026
our directors
directors of the Company
Amount not stated

Indemnification agreements with each director covering expenses, judgments, fines and settlements arising from board service

With the Company Open in proxy
our executive officers
executive officers of the Company
Amount not stated

Employment-related agreements providing compensatory and certain change in control benefits

With the Company Open in proxy
our executive officers and directors
executive officers and directors of the Company
Amount not stated

Stock options granted to executive officers and directors, and restricted stock units granted to certain executive officers

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support